CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF RETINOBLASTOMA: Correlation with Prognosis in a Turkish Pediatric Oncology Center

REFERENCES

• Albert D M. Historic review of retinoblastoma. Ophthalmology 1987; 94: 654–662
   PubMedGoogle Scholar
• Hurwitz R L, Shields C L, Shields J A. Retinoblastoma. Principles and Practice of Pediatric Oncology, P A Pizzo, D G Poplack. Lippincott Williams Wilkins, Philadelphia 2002; 826–846
   Google Scholar
• Antoneli C BG, Steinhorst F, Ribeiro K CB. Extraocular retinoblastoma: a 13-year experience. Cancer 2003; 98: 1292–1298
   PubMed Web of Science ®Google Scholar
• Butros L J, Abramson D H, Dunkel I J. Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences. Pediatrics 2002; 109: E45
   PubMed Web of Science ®Google Scholar
• Chantada G L, Fandino A, Manzitti J. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child 1999; 80: 171–174
   PubMed Web of Science ®Google Scholar
• Chantada G, Fandino A, Casak S. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol 2003; 40: 158–161
   PubMedGoogle Scholar
• Gunalp I, Gunduz K, Arslan Y. Retinoblastoma in Turkey: treatment and prognosis. Jpn J Ophthalmol 1996; 40: 95–102
   PubMed Web of Science ®Google Scholar
• Gutierrez A F, Mex A MS, Arangure J MM. Clinical and social social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol 2002; 39: 25–31
   PubMedGoogle Scholar
• Shields C L, De Potter P, Himmelstein B. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1330–1338
   PubMedGoogle Scholar
• Sanders B M, Draper G J, Kingston J E. Retinoblastoma in Great Britain 1969–80: incidence, treatment and survival. Br J Ophthalmol 1988; 72: 576–583
   PubMed Web of Science ®Google Scholar
• Kopelman J E, Mclean I W, Rosenberg S H. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 1987; 94: 371–377
   PubMed Web of Science ®Google Scholar
• Finger P T, Czechonska G, Demirci H, Rausen A. Chemotherapy for retinoblastoma: a current topic. Drugs 1999; 58: 983–996
   PubMedGoogle Scholar
• Sussman D A, Escalona-Benz E, Benz M S. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol 2003; 121: 979–984
   PubMed Web of Science ®Google Scholar
• Gombos D S, Kelly A, Coen P G. Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age. Br J Ophthalmol 2002; 86: 80–83
   PubMed Web of Science ®Google Scholar
• Gunalp I, Gunduz K, Arslan Y. Retinoblastoma in Turkey: diagnosis and clinical characteristics. Ophthalmic Genet 1996; 7: 21–27
   Google Scholar
• Finger P T, Harbour J W, Karcioglu Z A. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol 2002; 47: 1–16
   PubMed Web of Science ®Google Scholar
• Marcus D M, Brooks S E, Leff G. Trilateral retinoblastoma: insights into histogenesis and management. Surv Ophthalmol 1998; 43: 59–70
   PubMedGoogle Scholar
• Tamboli A, Podgor J M, Horm W J. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990; 108: 128–132
   PubMedGoogle Scholar
• Schultz K R, Ranade S, Neglia J P, Ravindranath Y. An increased frequency of retinoblastoma at a rural regional Referral Hospital in Miraj, Maharashtra, India. Cancer 1993; 72: 282–286
   PubMed Web of Science ®Google Scholar
• Wang A G, Hsu W M, Hsia W W. Clinicopathologic factors related to metastasis in retinoblastoma. J Pediatr Ophthalmol Strabismus 2001; 38: 166–171
   PubMed Web of Science ®Google Scholar
• Sant M, Capocaccia R, Badioni V. EUROCARE Working Group. Survival for retinoblastoma in Europe. Eur J Cancer. 2001; 37: 730–735
   Google Scholar
• Abramson D H, Frank C M, Susman M. Presenting signs of retinoblastoma. J Pediatr 1998; 132: 505–508
   PubMed Web of Science ®Google Scholar
• Abramson D H, Beaverson K, Sangani P. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics 2003; 112: 1248–1255
   PubMed Web of Science ®Google Scholar
• Balasubramanya R, Pushker N, Bajaj M S. Atypical presentations of retinoblastoma. J Pediatr Ophthalmol Strabismus 2004; 41: 18–24
   PubMed Web of Science ®Google Scholar
• Kao L Y, Su W W, Lin Y W. Retinoblastoma in Taiwan: survival and clinical characteristics 1978–2000. Jpn J Ophthalmol 2002; 46: 577–580
   PubMedGoogle Scholar
• Rodriguez-Galindo C, Wilson M W, Haik B G. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003; 21: 2019–2025
   PubMed Web of Science ®Google Scholar
• Shields C L, Gorry T, Shields J A. Outcome of eyes with unilateral sporadic retinoblastoma based on the initial external findings by the family and the pediatrician. J Pediatr Ophthalmol Strabismus 2004; 41: 143–149
   PubMedGoogle Scholar
• Shields C L, Honavar S G, Meadows A T. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002; 133: 657–664
   PubMed Web of Science ®Google Scholar
• Khelfaoui F, Validire P, Auperin A. Histopathologic risk factors in retinoblastoma. Cancer 1996; 7: 1206–1213
   Google Scholar
• Shields C L, Shields J A. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999; 36: 8–18
   PubMedGoogle Scholar
• Benz M S, Scott I U, Murray T G. Complications of systemic chemotherapy as treatment of retinoblastoma. Arch Ophthalmol 2000; 118: 577–578
   PubMedGoogle Scholar
• Shields C L, Shields J A, Baez K. Optic nerve invasion of retinoblastoma. Cancer 1994; 73: 692–698
   PubMed Web of Science ®Google Scholar
• Shields C L, Shelil A, Cater J. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Arch Ophthalmol 2003; 121: 1571–1576
   PubMedGoogle Scholar
• Lumbroso L, Doz F, Urbieta M. Chemothermotherapy in the management of retinoblastoma. Ophthalmology 2002; 109: 1130–1136
   PubMed Web of Science ®Google Scholar
• Mouratova T. Retinoblastoma in Uzbekistan. Bull Soc Belge Ophthalmol 2003; 289: 63–69
   Google Scholar